SG11202102139YA - Network methods for neurodegenerative diseases - Google Patents
Network methods for neurodegenerative diseasesInfo
- Publication number
- SG11202102139YA SG11202102139YA SG11202102139YA SG11202102139YA SG11202102139YA SG 11202102139Y A SG11202102139Y A SG 11202102139YA SG 11202102139Y A SG11202102139Y A SG 11202102139YA SG 11202102139Y A SG11202102139Y A SG 11202102139YA SG 11202102139Y A SG11202102139Y A SG 11202102139YA
- Authority
- SG
- Singapore
- Prior art keywords
- neurodegenerative diseases
- network methods
- network
- methods
- neurodegenerative
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/372—Analysis of electroencephalograms
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Databases & Information Systems (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Software Systems (AREA)
- Artificial Intelligence (AREA)
- General Engineering & Computer Science (AREA)
- Psychology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- High Energy & Nuclear Physics (AREA)
- Computing Systems (AREA)
- Radiology & Medical Imaging (AREA)
- General Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Psychiatry (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2018/073906 WO2020048593A1 (en) | 2018-09-05 | 2018-09-05 | Network methods for neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202102139YA true SG11202102139YA (en) | 2021-04-29 |
Family
ID=63592691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202102139YA SG11202102139YA (en) | 2018-09-05 | 2018-09-05 | Network methods for neurodegenerative diseases |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210193322A1 (en) |
| EP (1) | EP3847664A1 (en) |
| JP (2) | JP7401531B2 (en) |
| KR (2) | KR20240132122A (en) |
| CN (1) | CN112955972A (en) |
| AU (1) | AU2018440060A1 (en) |
| CA (1) | CA3111000A1 (en) |
| SG (1) | SG11202102139YA (en) |
| WO (1) | WO2020048593A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7507025B2 (en) | 2020-07-22 | 2024-06-27 | 靖恵 満倉 | DIAGNOSIS SUPPORT SYSTEM, DIAGNOSIS SUPPORT METHOD, AND DIAGNOSIS SUPPORT PROGRAM |
| US11147454B1 (en) | 2021-02-19 | 2021-10-19 | Omniscient Neurotechnology Pty Limited | Medical imaging with functional architecture tracking |
| CN115590465A (en) * | 2021-07-08 | 2023-01-13 | 丹阳慧创医疗设备有限公司（Cn） | Diagnosis device, diagnosis equipment and diagnosis system for cognitive disorder |
| WO2023048557A1 (en) * | 2021-09-27 | 2023-03-30 | Genting Taurx Diagnostic Centre Sdn Bhd | Determining an indication as to whether a patient has a neurocognitive disease |
| KR102427709B1 (en) | 2021-11-26 | 2022-08-01 | 주식회사 피맥스 | Multi-modality medical images analysis method and apparatus for diagnosing brain disease |
| CN114376558B (en) * | 2022-03-24 | 2022-07-19 | 之江实验室 | Brain atlas individuation method and system based on magnetic resonance and twin map neural network |
| CN117690537B (en) * | 2024-02-04 | 2024-06-18 | 中日友好医院(中日友好临床医学研究所) | Cross-modal method and device for QSM (quad slit) and brain atrophy and brain connection group association |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2013191T6 (en) | 2006-03-29 | 2019-07-31 | Wista Laboratories Ltd. | 3,7-diamino-10h-phenothiazine salts and their use |
| EP2227766A2 (en) * | 2007-11-05 | 2010-09-15 | Wista Laboratories Ltd. | Systems for clinical trials |
| US20130060125A1 (en) * | 2010-04-16 | 2013-03-07 | Applied Brain And Vision Sciences Inc. | Encephalography method and apparatus incorporating independent component analysis and a spectral shaping filter |
| US8965077B2 (en) * | 2010-05-18 | 2015-02-24 | Siemens Corporation | Methods and systems for fast automatic brain matching via spectral correspondence |
| US9737230B2 (en) * | 2011-01-06 | 2017-08-22 | The Johns Hopkins University | Seizure detection device and systems |
| CN103649061B (en) | 2011-02-11 | 2016-04-20 | 维斯塔实验室有限公司 | Thiodiphenylamine diamine salts and its purposes |
| US9510756B2 (en) * | 2012-03-05 | 2016-12-06 | Siemens Healthcare Gmbh | Method and system for diagnosis of attention deficit hyperactivity disorder from magnetic resonance images |
| WO2014153466A2 (en) * | 2013-03-20 | 2014-09-25 | Cornell University | Methods and tools for analyzing brain images |
| US9265441B2 (en) * | 2013-07-12 | 2016-02-23 | Siemens Aktiengesellschaft | Assessment of traumatic brain injury |
| WO2016016833A1 (en) * | 2014-08-01 | 2016-02-04 | Istituto Nazionale Di Fisica Nucleare | Computer method for classification of brain images |
| TWI745321B (en) | 2016-01-08 | 2021-11-11 | 馬來西亞商雲頂圖爾斯診斷中心有限公司 | Method and system for determining network connections |
| US20190083805A1 (en) * | 2016-03-28 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Detecting or treating post-traumatic stress syndrome |
| WO2018019823A1 (en) | 2016-07-25 | 2018-02-01 | Wista Laboratories Ltd. | Administration and dosage of diaminophenothiazines |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
-
2018
- 2018-09-05 KR KR1020247028412A patent/KR20240132122A/en active Search and Examination
- 2018-09-05 WO PCT/EP2018/073906 patent/WO2020048593A1/en unknown
- 2018-09-05 AU AU2018440060A patent/AU2018440060A1/en active Pending
- 2018-09-05 JP JP2021512400A patent/JP7401531B2/en active Active
- 2018-09-05 CN CN201880099123.1A patent/CN112955972A/en active Pending
- 2018-09-05 CA CA3111000A patent/CA3111000A1/en active Pending
- 2018-09-05 KR KR1020217010013A patent/KR102700017B1/en active Application Filing
- 2018-09-05 US US17/272,885 patent/US20210193322A1/en active Pending
- 2018-09-05 SG SG11202102139YA patent/SG11202102139YA/en unknown
- 2018-09-05 EP EP18769952.5A patent/EP3847664A1/en active Pending
-
2023
- 2023-12-07 JP JP2023207311A patent/JP2024023602A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018440060A1 (en) | 2021-04-15 |
| KR20240132122A (en) | 2024-09-02 |
| EP3847664A1 (en) | 2021-07-14 |
| CA3111000A1 (en) | 2020-03-12 |
| KR20210056386A (en) | 2021-05-18 |
| JP2022503641A (en) | 2022-01-12 |
| KR102700017B1 (en) | 2024-08-29 |
| WO2020048593A1 (en) | 2020-03-12 |
| US20210193322A1 (en) | 2021-06-24 |
| JP7401531B2 (en) | 2023-12-19 |
| CN112955972A (en) | 2021-06-11 |
| JP2024023602A (en) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201917181D0 (en) | No details | |
| GB201910775D0 (en) | No Details | |
| GB201917180D0 (en) | No details | |
| GB201917178D0 (en) | No details | |
| SG11202102139YA (en) | Network methods for neurodegenerative diseases | |
| GB202017924D0 (en) | No details | |
| CA185743S (en) | Step system | |
| GB201801676D0 (en) | Database system | |
| GB201918422D0 (en) | No details | |
| GB201908106D0 (en) | No details | |
| GB201918330D0 (en) | No details | |
| GB201803724D0 (en) | Methods | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| GB201802486D0 (en) | Methods | |
| IL273929A (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11202007342QA (en) | Methods | |
| GB201905867D0 (en) | No details | |
| GB201805466D0 (en) | Methods | |
| IL282108A (en) | Preparation method for efinaconazole | |
| GB202004524D0 (en) | No details | |
| SG11202007979UA (en) | Dihydrochromene derivative | |
| SG11202006837XA (en) | Dihydroindolizinone derivative | |
| GB202007832D0 (en) | No details | |
| GB201814451D0 (en) | Methods | |
| GB201802257D0 (en) | Network |